Research team for Abiomed's battery heart expands
This article was originally published in Clinica
Abiomed is preparing for clinical trials of its battery-powered heart after finalising several collaborative agreements with five US medical centres, as part of its drive to expand its project and research team. The company is building a fully-implantable heart as a permanent replacement for a diseased organ.
You may also be interested in...
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.